Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-31T17:33:28.331Z Has data issue: false hasContentIssue false

12 - Role of the colony-stimulating factors in other disease states

Published online by Cambridge University Press:  04 August 2010

Donald Metcalf
Affiliation:
Walter and Eliza Hall Institute of Medical Research, Victoria
Nicos Anthony Nicola
Affiliation:
Walter and Eliza Hall Institute of Medical Research, Victoria
Get access

Summary

The possibility must be considered that abnormally high or low levels of CSF, either systematic or at a local level, produce or contribute to disease development. Information on this issue remains somewhat limited because of the technical difficulty of estimating local-tissue CSF concentrations. The special question of the relation of the CSFs to myeloid leukemia development will be discussed in Chapter 13.

Consequences of sustained excess levels of CSFs

Several models have been used to examine the consequences in mice of the sustained elevation of CSF levels. These have involved the production of GM-CSF transgenic mice with the inserted transgene under a viral long terminal repeat promoter (Lang et al., 1987) or the repopulation of irradiated mice by hemopoietic cells in which a retrovirus had been used to insert a CSF cDNA, again under the control of a strong viral promoter (Johnson et al., 1989; Chang et al., 1989a,b). Both maneuvers have achieved in mice the sustained elevation of circulating CSF levels(100- fold in the transgenic model and up to 10,000-fold for the repopulation models). However, in both types of model, the situation is artificial in terms of the cell types producing the additional CSF. In the case of the GM-CSF transgenic mice, expression of the transgene appeared to be restricted to macrophages, while, inevitably in the repopulation models, the cells expressing the inserted genes were entirely of hemopoietic type.

Type
Chapter
Information
The Hemopoietic Colony-stimulating Factors
From Biology to Clinical Applications
, pp. 215 - 226
Publisher: Cambridge University Press
Print publication year: 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×